Dublin, April 17, 2017 -- Research and Markets has announced the addition of the "Quantitative Immunoassay Life Science Dashboard Series 3" report to their offering.
Immunoassays are commonly used laboratory tests for identification and quantification of proteins. With a range of applications in diagnosis of cancer, immunology and disease research, immunoassays are widely used by scientists in academia and industry.
The 2016 Quantitative Immunoassay Dashboard is the third in a series that characterizes the dynamic market for immunoassay products.
This 2016 Dashboard provides a snapshot of the current market landscape that is compared with data from all of the previous Quantitative Immunoassay Dashboards , and was developed from responses to a 48-question survey completed by 592 scientists located in North America and Europe.
This Dashboard reveals key market indicators for the Quantitative Immunoassay market as a whole as well as for the following techniques representing market sub-segments:
- Colorimetric ELISA
- Chemiluminescent ELISA
- Fluorescent ELISA
- Electrochemiluminescence immunoassays
- Bead-based immunoassays
- This report is focused on the use of Quantitative Immunoassay products in life science research market.
The following suppliers were surveyed for this report:
- Abcam
- Affymetrix/eBioscience
- BD Biosciences
- Bio-Rad
- GE Healthcare/Amersham
- KPL/SeraCare
- Luminex (direct)
- Meso Scale Discovery
- Perkin Elmer
- R&D Systems/Biotechne
- Roche Applied Science
- Sigma/EMD Millipore
- Thermo Fisher Scientific (including Life Technologies, Pierce, Invitrogen, Novex, Molecular Probes)
Key Topics Covered:
1. Executive Summary
2. Dashboard "At A Glance"
3. Market Opportunity Matrix
4. Respondent Qualification
5. Demographics
6. Frequency of Performance: Life Science Techniques
7. Frequency of Use: Immunoassay Methods & Additional Protein Related Method
8. Co-Performance: Quantitative Immunoassay Methods & Life Science Techniques
9. Throughput, Growth Rates, Price & Monthly Spend
10. Market Size
11. Percentage of Spend with Suppliers of Immunoassay Products
12. Customer Satisfaction & Interest in Switching
13. Product Feature Influencing Purchase Decisions
14. Primary Focus/Application of Protein Analysis Research & Use of Protein Classes/Categories
15. Desired Changes to Immunoassay Products
16. Appendix I: Supporting Data
17. Appendix II: The Capabilities and Life Science Dashboards TM Available
Companies Mentioned
- Abcam
- Affymetrix/eBioscience
- BD Biosciences
- Bio-Rad
- GE Healthcare/Amersham
- KPL/SeraCare
- Luminex (direct)
- Meso Scale Discovery
- Perkin Elmer
- R&D Systems/Biotechne
- Roche Applied Science
- Sigma/EMD Millipore
- Thermo Fisher Scientific (including Life Technologies, Pierce, Invitrogen, Novex, Molecular Probes)
For more information about this report visit http://www.researchandmarkets.com/research/ds2x4b/quantitative
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology, In Vitro Diagnostics


WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
Nomura Shares Drop After Profit Miss Despite Strong Revenue Growth
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Strait of Hormuz Shipping Crisis Deepens as Traffic Plunges Amid Iran-U.S. Tensions
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases
Chinese Chip Stocks Surge on AI Boom and Domestic Tech Push
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
DeepSeek V4 Launch Signals China’s Growing AI Independence with Huawei Chips
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
U.S. Warns Allies Over Alleged Chinese AI IP Theft Linked to DeepSeek
Google Secures Pentagon AI Deal for Classified Projects 



